The Reduction in Yield (RIY) disclosure requirement for authorised funds is 'innacurate and misleading' and should be scrapped, the IMA says.
Its call comes in response to an FSA consultation paper which proposes authorised funds should continue to publish RIY information. RIY is a measure of the impact of charges on a fund. It takes account of initial and ongoing charges which are measured over a fixed period, usually 10 years. However, the IMA believes the requirement should be scrapped as it brings ‘no apparent benefit’ to consumers and can be potentially misleading when applied to funds. Julie Patterson, director of authorised funds and tax at IMA, says RIY is not a clearly understood measure of the cost of investing. ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes